THYMOSI ANew

                                                                                                                                                                                                            

Contents
  • Vial: Thymosin Alpha-1, 5mg × 5      
  • Ampoule: 2ml Bacteriostatic Water for Injection IP       
Description

THYMOSI A is a potent immunomodulatory peptide formulated with Thymosin Alpha-1, a naturally occurring thymic peptide known for its critical role in regulating and enhancing immune function.

It works by stimulating T-cell production and activity, improving immune surveillance, and enhancing the body's defense against infections, viruses, and inflammatory conditions. Thymosin Alpha-1 also supports immune system balance by modulating cytokine response and reducing excessive inflammation.

 THYMOSI A is widely utilized in immune-support protocols, recovery enhancement, and as an adjunct therapy in chronic infections, liver disorders, and immune-compromised states, helping promote faster recovery and overall physiological resilience.      

Administration Intramuscular (IM) or Subcutaneous (SC) injection.
Storage
  • Before reconstitution: Store at room temperature, away from heat and direct sunlight.     
  • After reconstitution: Refrigerate between 2–8°C.
      
Dosage  Initial: 500–1000 mcg/day. Frequency and duration may vary based on condition and response.

 Half-life: ~2–3 hours.      
Indication  THYMOSI A may be prescribed in cases of:           
  • Weakened immune function
  • Chronic infections and viral conditions
  • Liver disorders     
  • Inflammatory diseases 
  • Immune-compromised states
  • Recovery support and immune enhancement
      
Contraindications Do not use THYMOSI A if:        
  • Hypersensitivity to Thymosin Alpha-1 or formulation components
  • Pregnancy and lactation
  • Autoimmune disorders (unless under strict medical supervision)
      
Special Precautions
  • Use cautiously in patients with autoimmune diseases.  
  • Monitor immune markers during prolonged use.
  • Not recommended without medical supervision.
  • Discontinue use if hypersensitivity or abnormal immune response occurs.
      
Adverse Drug Reactions
  • Generally well tolerated    
  • Common: Injection site reactions, fatigue, headache
  • Occasional: Mild fever
  • Rare: Allergic reactions
      
Disclaimer  Images displayed on the website are for representational purposes only which may differ from the actual purchased product. The company may change or alter the packaging design without notice.